March 25, 2022

60: Improving Care and Raising Awareness for NMOSD

27 minutes

Welcome to the NeurologyLive® Mind Moments™ podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.

In this episode, we spoke with Friedmann Paul, MD, head, Clinical Neuroimmunology Research Group, NeuroCure Clinical Research Center, and head, Clinical and Experimental Neuroimmunology, Experimental and Clinical Research Center, Charité–Universitätsmedizin Berlin. He shared his perspective on the state of care in neuromyelitis optica spectrum disorder (NMOSD), the need to raise awareness for symptomatic care and patient challenges, and the potential of novel therapeutic approaches to improve care.

Episode Breakdown:

2:00 – State of diagnosis and care for NMOSD and similar disorders

6:00 – Role of NMOSD Awareness Month and advocacy efforts

8:45 – Current challenges with symptomatic management

11:20 – Multidisciplinary communication, coordination, and collaboration

13:05 – Neurology News Minute

16:45 – The potential of self-tolerization and curing NMOSD

19:05 – Nonpharmacologic approaches to care

20:40 – The need to improve physician awareness and education

22:45 – Advice for communicating the diagnosis to patients

24:45 – The need for patient advocacy groups

The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:

Donepezil Transdermal System Wins FDA Approval to Treat Alzheimer Disease Dementia

Sarepta Details Phase 3 EMBARK Study in DMD

Ganaxolone Wins Landmark Approval for CDKL5 Deficiency Disorder

Thanks for listening to the NeurologyLive® Mind Moments™ podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

...more

View all episodes

By NeurologyLive

4.6

1010 ratings